Trial Profile
KD-295 phase II/III study
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs KD 295 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 14 Jun 2016 New trial record
- 29 Sep 2015 Status changed from recruiting to completed.